Immunomedics, Inc.

Immunomedics, Inc. is a New Jersey-based biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. It has developed a number of advanced technologies that allow it to create humanized antibodies that can be used either alone in unlabeled or naked form, or conjugated with radioactive isotopes, chemotherapeutics or toxins, in each case to create targeted agents. It has licensed its product candidate epratuzumab, to UCB S.A. (UCB), for the treatment of all autoimmune disease indications. ...


There are no scholarships at this time


There are no events at this time

Company Data on Immunomedics, Inc.
provided by Owler


Immunomedics, Inc. is hiring for these positions

Show me: All available jobs